Is SLS up or down today?
SLS is down 5.42% today, last at 9.16. This stock moved -5.42% versus the prior close.
SLS · SLS
SLS (SLS) is trading at 9.16, down 5.42% on the session. SLS sits at the 54% mark of its 52-week range, carries a 14-day RSI of 36, and trades below its 50-day average. Over the past month it is down 19.19%.
Leading the coverage: “Sellas Life Sciences: Too Many Survivors For Its Own Trial Plan (NASDAQ:SLS) - Seeking Alpha” (Google News Company, 6d ago). SLS is -19.26% since story.
SLS trades on a trailing P/E of 12.1 and is running 18.97% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
SLS is down 5.42% today, last at 9.16. This stock moved -5.42% versus the prior close.
Leading the coverage: “Sellas Life Sciences: Too Many Survivors For Its Own Trial Plan (NASDAQ:SLS) - Seeking Alpha” (Google News Company, 6d ago). SLS is -19.26% since story. Dominant story: SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus (2 sources, neutral) RSI is 36 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus
SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus - Yahoo Finance
SLS, IBRX Rise Premarket: Funds Raise Their Bets As J&J Stays ‘On The Lookout’ For Deals - Stocktwits
SLS Stock Jumps Ahead Of CEO’s Fox Appearance: Retail Bets AML Readout Could Spark Big Pharma Bidding War - Stocktwits
Nasdaq, S&P 500 Futures Edge Lower Before Fed Call, Earnings Rush: Why POET, MRVL, NVDA, ORCL, SLS Are In Focus - Stocktwits